🇺🇸 FDA
Patent

US 10668161

Therapeutic hyperbranched polyglycerol encapsulated biomolecules

granted A61KA61K38/43A61K38/443

Quick answer

US patent 10668161 (Therapeutic hyperbranched polyglycerol encapsulated biomolecules) held by The Regents of the University of California expires Mon May 28 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Jun 02 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 28 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
15
CPC classes
A61K, A61K38/43, A61K38/443, A61K38/51, A61K47/59